Table II.
Female | Male | P value | |||
---|---|---|---|---|---|
| |||||
Intact repair | |||||
No. patients | 10,118 | 41,018 | |||
Diameter, cm | 5.4 | 5.0–5.9 | 5.5 | 5.1–6.0 | <.001 |
ASI, cm/m2 | 3.1 | 2.8–3.5 | 2.7 | 2.4–3.1 | <.001 |
AHI, cm/m | 3.3 | 3.1–3.6 | 3.1 | 2.9–3.5 | <.001 |
BSA, m2 | 1.7 | 1.6–1.9 | 2.0 | 1.9–2.2 | <.001 |
Height, m | 1.6 | 1.6–1.7 | 1.7 | 1.7–1.8 | <.001 |
EVAR | 7893 | 78 | 34,643 | 85 | <.001 |
Age, y | 75 | 69–80 | 73 | 67–79 | <.001 |
Race/ethnicity | <.001 | ||||
Non-Hispanic white | 8768 | 89 | 36,588 | 92 | |
Black or African American | 710 | 7.2 | 1570 | 3.9 | |
Hispanic | 249 | 2.5 | 1094 | 2.7 | |
Asian | 101 | 1.0 | 535 | 1.3 | |
Other | 44 | 0.5 | 151 | 0.4 | |
Underweight | 539 | 5.3 | 728 | 1.8 | <.001 |
Obese | 2957 | 29 | 12,922 | 32 | <.001 |
Current smoker | 3665 | 36 | 13,008 | 32 | <.001 |
Hypertension | 8605 | 85 | 34,170 | 83 | <.001 |
Insulin-dependent diabetes | 322 | 3.2 | 1474 | 3.6 | .045 |
Coronary artery disease | 3176 | 31 | 18,204 | 44 | <.001 |
CHF | <.001 | ||||
None | 9070 | 90 | 36,196 | 88 | |
Asymptomatic/mild | 914 | 9.0 | 4141 | 10 | |
Moderate/severe | 130 | 1.3 | 660 | 1.6 | |
COPD | 4203 | 42 | 12,920 | 32 | <.001 |
CKD | 609 | 6.1 | 1462 | 3.6 | <.001 |
Prior aortic aneurysm repair | 322 | 3.2 | 1428 | 3.5 | .14 |
Family history of AAA | 1048 | 10 | 3575 | 8.8 | <.001 |
Preoperative ASA/aspirin use | 6284 | 62 | 27,526 | 67 | <.001 |
Preoperative beta-blocker use | 5626 | 56 | 23,178 | 57 | .10 |
Preoperative statin use | 6847 | 68 | 29,704 | 72 | <.001 |
Rupture repair | |||||
No. patients | 978 | 3533 | |||
Diameter, cm | 6.7 | 5.7–7.8 | 7.7 | 6.4–9.0 | <.001 |
ASI, cm/m2 | 3.8 | 3.2–4.5 | 3.7 | 3.1–4.4 | .030 |
AHI, cm/m | 4.1 | 3.6–4.8 | 4.3 | 3.6–5.1 | <.001 |
BSA, m2 | 1.7 | 1.6–1.9 | 2.0 | 1.9–2.2 | <.001 |
Height, m | 1.6 | 1.5–1.7 | 1.8 | 1.7–1.9 | <.001 |
EVAR | 562 | 58 | 2097 | 60 | .29 |
Age, y | 76 | 70–83 | 72 | 65–78 | <.001 |
Race/ethnicity | .001 | ||||
Non-Hispanic white | 834 | 88 | 3075 | 90 | |
Black or African American | 80 | 8.5 | 184 | 5.4 | |
Hispanic | 23 | 2.4 | 97 | 2.8 | |
Asian | 6 | 0.6 | 55 | 1.6 | |
Other | 3 | 0.3 | 7 | 0.2 | |
Underweight | 73 | 7.5 | 102 | 2.9 | <.001 |
Obese | 320 | 33 | 1187 | 34 | .61 |
Current smoker | 409 | 42 | 1619 | 46 | .019 |
Hypertension | 784 | 80 | 2730 | 78 | .068 |
Insulin-dependent diabetes | 35 | 3.6 | 117 | 3.3 | .69 |
Coronary artery disease | 236 | 24 | 1132 | 32 | <.001 |
CHF | .18 | ||||
Asymptomatic/mild | 91 | 9.4 | 314 | 9.0 | |
Moderate/severe | 26 | 2.7 | 62 | 1.8 | |
COPD | 361 | 37 | 999 | 29 | <.001 |
CKD | 171 | 18 | 418 | 12 | <.001 |
Prior aortic aneurysm repair | 47 | 4.8 | 232 | 6.6 | .041 |
Family history of AAA | 58 | 6.1 | 200 | 5.8 | .78 |
Preoperative ASA/aspirin use | 356 | 37 | 1412 | 41 | .054 |
Preoperative beta-blocker use | 388 | 40 | 1345 | 39 | .31 |
Preoperative statin use | 406 | 42 | 1518 | 44 | .46 |
AAA, Abdominal aortic aneurysm; AHI, aortic height index; ASA, acetylsalicylic acid; ASI, aortic size index; BSA, bodysurface area; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; EVAR, endovascular aneurysm repair; Obese, body mass index of 30 or above; Underweight, body mass index below 18.5.
Categorical variables are presented as number (%) and continuous variables as median (interquartile range).